Teva Announces First Approval and Launch of Generic Lovaza® Capsules in the United States
April 08, 2014 at 08:46 AM EDT
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announces the approval of the generic equivalent to Lovaza® (Omega-3-Acid Ethyl Esters ...
